US 2006/0142256 A1 · Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometricosis

Abstract

The invention relates to a method of treating endometriosis using a combination of an aromatase inhibitor, a progestin and an oestrogen. The invention also relates to pharmaceutical formulations comprising said combination.

Claims25

Dependent claims

1-10. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

10/543,584Filed 3 Feb 2004

Priority

GB 0302572.35 Feb 2003

Published

29 Jun 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 31/4184
1,3-Diazoles: condensed with carbocyclic rings, e.g. benzimidazoles
A61K 31/4196
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2,4-Triazoles
A61K 31/567
Not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol: substituted in position 17 alpha, e.g. mestranol, norethandrolone

Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometricosis

Life of this patent

Abstract

Claims25

Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometricosis

Life of this patent

Abstract

Claims25